Skip to content

About IPI

Our mission is to advance protein science to accelerate research and improve human health.

Unlocking protein biology

IPI is a nonprofit protein research institute located on the Harvard Medical School campus. In addition to novel research, we provide scientists access to protein tools, high-quality recombinant antibodies and learning opportunities to empower groundbreaking work and advance biomedical understanding.

Two scientists in lab coats laughing.

Our research

IPI scientists apply their protein science expertise and foster collaborations to investigate biological questions, particularly in neuroscience.

Explore our research

Our community

Through courses, workshops and other events, we share protein knowledge and equip the next generation of scientists to better tackle future challenges.

View learning opportunities
A man and a woman in front of a computer

Our people

Our scientists combine deep technical skills with collaborative teamwork to creatively solve complex problems in biomedical research.

Meet the IPI team

How we are different

As a nonprofit institute, IPI is motivated by scientific need and impact — rather than profit.

Through innovative technologies and lab automation, we achieve high-throughput production of high-quality synthetic recombinant antibodies at scale.

We work closely with scientific communities, using a unique community validation model to engage a global team of researchers in testing the applicability of our tools in real-world experimentation. 

Man working in cell biology lab.

Building an institute

  • 2015

    Tim Springer hatches the idea of IPI, hosting the first Board meeting in his home.

  • 2017

    With its yeast display library completed, IPI officially launches.

  • 2018

    IPI relocates to the Harvard Medical School campus.

  • 2020

    IPI licenses its first antibody and launches its antibody validation campaign.

  • 2022

    IPI appoints Kenneth Fasman as its president and first CEO.

  • 2023

    IPI announces its partnership with Addgene and hosts its first symposium, IPI Surfacing.

  • 2024

    IPI commercializes its first antibodies via Addgene and launches its open science model.

  • 2025

    IPI launches its first hands-on education course.

Test our antibodies

Gain early access to novel proteins by testing our beta-stage antibodies in your lab.

Pursue a joint project

IPI welcomes collaborations large and small in an effort to accelerate protein research.

Use our proteins

Let our growing catalog of antibodies and protein tools power your next discovery.

Back To Top